Navigation Links
Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
Date:10/22/2007

SWARTZ CREEK, Mich., Oct. 22 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Atheer A. Kaddis has joined the company's executive management team. Dr. Kaddis will serve as Vice President of Managed Markets for the company. He reports directly to Diplomat Specialty Pharmacy's President and CEO, Philip Hagerman.

"The addition of Atheer Kaddis offers Diplomat the Managed Care expertise we need to further develop competitive, cost saving specialty programs making us an attractive choice for health care plans," comments Hagerman. "Atheer's wealth of knowledge in the managed care arena will be invaluable to us as we continue to expand nationally."

Dr. Kaddis stated, "I believe that Diplomat Specialty Pharmacy is a great organization that has made a commitment to help its patients, providers, and customers navigate the complexities of specialty pharmacy in order to provide access to cost-effective, high quality care. I am very excited to be a part of the Diplomat Specialty Pharmacy team."

Before joining Diplomat, Dr. Kaddis worked for Blue Cross Blue Shield of Michigan (BCBSM) as their Director of Pharmacy Services-Clinical. As the Director of Pharmacy Services-Clinical, Dr. Kaddis was responsible for the development and implementation of the specialty pharmacy program, development of the prescription drug formulary, development of clinical pharmacy programs, drug information, provider education, and customer liaison activities. Dr. Kaddis' previous experience also includes the position of Associate Director, Clinical Services at Merck-Medco. Dr. Kaddis is a graduate of the Doctor of Pharmacy program at Wayne State University in Detroit, Michigan.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

Executive Assistant

Diplomat Specialty Pharmacy

810.720.4452

kkarns@diplomatpharmacy.com


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Germantown drug company hires pharma veteran James Davidson as COO
3. Merge Healthcare hires new VP of finance
4. PDS hires new VP, buys former health club building
5. Siemens health services president calls IT benefits unassailable
6. Wisconsin IT association names Gee president, CEO
7. Merge Healthcare promotes Bowers to president
8. Quintessence Biosciences names new president
9. VanderSanden appointed president of AT&T Wisconsin
10. Merge president steps down in wake of shareholder suits
11. Milwaukees PointOne appoints new president and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):